Podocyte-specific VEGF down-regulation and pathophysiological development

IUBMB Life. 2010 Sep;62(9):677-83. doi: 10.1002/iub.368.

Abstract

It is well-known that vascular endothelial growth factor (VEGF) plays a key role in development and pathology, but its function in normal adult tissues is rarely understood. Increased use of anti-angiogenic therapies targeting VEGF in human pathologies have shown more and more adverse effects. In this report, a conditional expression model (Tet-On system) was used to down-regulate podocyte VEGF in adult mice, which resulted in many kidney problems, characterized by glomerular morphological changes, proteinuria, reduced water consumption and urination, increased urine electro-conductivity, as well as high susceptibility to BSA stress. Our findings indicated that podocyte-specific VEGF down-regulation resulted in poor kidney performance and led mice to be more susceptible to further kidney damages.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Disease Models, Animal
  • Down-Regulation*
  • Immunohistochemistry
  • Kidney Glomerulus / pathology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Podocytes* / pathology
  • Reverse Transcriptase Polymerase Chain Reaction
  • Vascular Endothelial Growth Factor A / metabolism*

Substances

  • Vascular Endothelial Growth Factor A